Publisher
Springer Science and Business Media LLC
Reference32 articles.
1. National Cancer Institute: Surveillance, Epidemiology, and End Results Program. https://seer.cancer.gov/statfacts/html/common.html. (Accessed October 24 2020).
2. T.E. Clancy, Surgery for Pancreatic Cancer, Hematol Oncol Clin North Am 29(4) (2015) 701-16.
3. G. Gemenetzis, V.P. Groot, A.B. Blair, D. Ding, S.S. Thakker, E.K. Fishman, J.L. Cameron, M.A. Makary, M.J. Weiss, C.L. Wolfgang, J. He, Incidence and risk factors for abdominal occult metastatic disease in patients with pancreatic adenocarcinoma, J Surg Oncol 118(8) (2018) 1277-1284.
4. J.A. Glant, J.A. Waters, M.G. House, N.J. Zyromski, A. Nakeeb, H.A. Pitt, K.D. Lillemoe, C.M. Schmidt, Does the interval from imaging to operation affect the rate of unanticipated metastasis encountered during operation for pancreatic adenocarcinoma?, Surgery 150(4) (2011) 607-16.
5. J. Insulander, S. Sanjeevi, M. Haghighi, T. Ivanics, A. Analatos, L. Lundell, M. Del Chiaro, Å. Andrén-Sandberg, C. Ansorge, Prognosis following surgical bypass compared with laparotomy alone in unresectable pancreatic adenocarcinoma, Br J Surg 103(9) (2016) 1200-8.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献